Eurasian chemical market


- Novartis Invests USD 140m in Pharmaceutical Plant in St. Petersburg
- Akrikhin Expanded its Portfolio by New Neurological Medicine
- Dalchempharm's Net Profit Rose 20.3% for 2011
- Valeant Pharmaceuticals Agrees to Acquire Natur Produkt in Russia
- Biofarma Earns USD 1.5m in 2011
- Borshchahivka Chemical and Pharmaceutical Plant Increased Net Revenues for January-March 2012
- Darnitsa Pharmaceutical Firm Ends 2011 in the Black
- Vinnytsiapharmacia Finishes 2011 in the Black
- Biokon Ends 2011 with Profit of USD 825,780
- Lubnypharm Ends 2011 with Profit of USD 487,960
- Farmacia Ends 2011 with Profit of USD 212,700
- Stirolbiopharm Earns USD 1.07m of Pre-Tax Profit in Q1, 2012
- Ukrainian Pharmaceutical Companies Announced Update on Net Revenues
- Sopharma Decides to Create Sopharma Ukraine Subsidiary
- Ukrainian Cabinet Approves of Transfer of Powers for Medications Quality and Safety Control to Pharmaceuticals Service
- Bangladeshi Pharmaceiticals to Enter Custom Union Market through Belarusian Door
- Pharmaceutical Boom in Kazakhstan in Q1, 2012
- Georgian Pharmaceuticals Production Increased 35% in 2011
- Ropharma Plans to Expand Output of its Drugs to 10% until 2015
- Ranbaxy Laboratories and Daiichi Sankyo to Start Production of Hypertension Drug in Romania
- Romanian Pharma Producers Worried by Current Clawback Tax

Our Partners
China Chemical Reporter CREON Energy
Conference and Exhibition, held under an informational support of the magazine "Eurasian chemical market"
19th Phenol / Acetone & Derivatives Технотекстиль | technotextil Nitrogen 2022 Barrier Paper Packaging for Food-Contact Грэйнтек RUPLASTICA